Form D · Venture Capital Fund

BIOVENTURES INVESTORS MEDTECH GROWTH CAPITAL, LP

Wellesley, MA · CIK 0001835848

Offering snapshot reported Dec 1, 2022 · SEC filing

Reported sold
$205M
Offering amount: $350M
Investors reported
3
Form D · investor count
Minimum accepted
$500K
Reported outside-investor minimum
First sale
Dec 10, 2020
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$102M$205MDec 16, 2020: $204,500,000.00Dec 16, 2020Dec 9, 2021: $204,500,000.00Dec 9, 2021Dec 1, 2022: $204,500,000.00Dec 1, 2022

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 1, 2022Amendment$204,500,000$0vs Dec 9, 20213SEC filing
Dec 9, 2021Amendment$204,500,000$0vs Dec 16, 20203SEC filing
Dec 16, 2020Initial$204,500,000No comparison3SEC filing

Offering details

Securities
Pooled investment fund
Exemptions
06b, 3C, 3C.1
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-383341

Source: Form D, filed Dec 1, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

BIOVENTURES INVESTORS MEDTECH GROWTH CAPITAL LP

Investment adviser: BIOVENTURES II MANAGEMENT CORPORATION

Gross asset value
$207M
Beneficial owners
4
ADV minimum commitment
$500K

Reported in Form ADV on Mar 26, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Custodian MORGAN STANLEY SMITH BARNEY LLC WELLESLEY, Massachusetts, United States Related to adviser: No
Provider details
Annual audit
No
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
No
External marketing
No

MORGAN STANLEY SMITH BARNEY LLC
SEC 8-170103

Filing source

Form ADV 2083071 · Mar 26, 2026 · Schedule D 7.B.(1), fund 805-4643468287

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jeffrey Barnes Executive
N/A Bio Ventures Med Tech Growth Capital Management Llc Executive
Jonathan Gertler Executive
Marc Goldberg Executive
James Lousararian Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
16 Laurel Avenue Suite 150
Wellesley, MA, 02481